Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to Australia

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Yanna KoIBD Sydney Organisation

Abstract

The incidences of the inflammatory bowel diseases (IBDs) Crohn's disease (CD) and ulcerative colitis (UC) are increasing, indicating gene-environment interactions. Migrants from low-IBD-prevalence countries to a high-prevalence country may help identify the relative contribution of environmental risk factors compared with native Caucasians. This prospective case-control study evaluated IBD environmental risk factors of Middle Eastern migrants (MEM) in Australia compared with matched Caucasian IBD subjects, MEM controls, Caucasian controls, and controls in the Middle East using adjusted odds ratios (aOR). A total of 795 subjects were recruited: 154 MEM cases (75 CD; 79 UC), 153 MEM controls, 162 Caucasian cases (85 CD; 77 UC), 173 Caucasian controls, and 153 controls in Lebanon. Smoking increased CD risk in MEM and Caucasians and reduced UC risk in Caucasians (aOR, 0.77; 95% CI, 0.41-0.98) but not MEM (aOR, 1.45; 95% CI, 0.80-2.62). Antibiotic use reduced the risk of MEM CD (aOR, 0.27; 95% CI, 0.11-0.67) and UC (aOR, 0.38; 95% CI, 0.18-0.80), but increased the risk in Caucasians (CD: aOR, 5.24; 95% CI, 2.13-12.90; and UC: aOR, 6.82; 95% CI, 2.67-17.38). Most hygiene markers (rural dwelling, pet ownership, pet feeding, and farm a...Continue Reading

References

Jan 13, 1996·BMJ : British Medical Journal·N P ThompsonA J Wakefield
May 10, 2000·Proceedings of the National Academy of Sciences of the United States of America·M F HammerB Bonne-Tamir
Nov 24, 2006·Mayo Clinic Proceedings·Suhal S MahidSusan Galandiuk
Jan 9, 2007·Inflammatory Bowel Diseases·Heitham Abdul-BakiAla I Sharara
May 15, 2007·Lancet·Daniel C Baumgart, Simon R Carding
Jan 30, 2009·Journal of Biosocial Science·Bernadette Barbour, Pascale Salameh
Jan 16, 2010·Journal of Gastroenterology and Hepatology·Richard B GearryMurray L Barclay
Oct 18, 2012·Alimentary Pharmacology & Therapeutics·P C Lunney, R W L Leong
Jan 22, 2013·Gut·Siew C NgUNKNOWN Epidemiology and Natural History Task Force of the International Organization of Inflammatory Bowel Disease (IOIBD)
Feb 28, 2014·World Journal of Gastroenterology : WJG·Yanna KoRupert W Leong

❮ Previous
Next ❯

Citations

Feb 26, 2016·Current Gastroenterology Reports·Ersilia M DeFilippisEllen J Scherl
May 31, 2016·Journal of Gastroenterology and Hepatology·James M Fulforth, Richard B Gearry
Dec 19, 2015·Journal of Gastroenterology and Hepatology·Weili SunChuanhua Yang
Jun 25, 2016·Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva·Peng Deng, Junchao Wu
Nov 29, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Ken LiuRupert W Leong
May 20, 2017·Alimentary Pharmacology & Therapeutics·O M DamasM T Abreu
Aug 5, 2017·Inflammatory Bowel Diseases·Kimberley W J van der SlootBehrooz Z Alizadeh
Aug 3, 2016·Inflammatory Bowel Diseases·Aurada Cholapranee, Ashwin N Ananthakrishnan
Sep 12, 2017·Alimentary Pharmacology & Therapeutics·L XuA N Ananthakrishnan
Feb 9, 2016·World Journal of Gastrointestinal Pharmacology and Therapeutics·Evangelia Legaki, Maria Gazouli
Jun 24, 2020·Journal of Crohn's & Colitis·Kimberley W J van der SlootGerard Dijkstra
Aug 10, 2018·Intestinal research·Santosh SanagapalliUNKNOWN IBD Sydney Organisation and the Asia-Pacific Crohn's and Colitis Epidemiology Study (ACCESS) Group
Apr 20, 2018·Nature Reviews. Gastroenterology & Hepatology·Tao ZuoSiew C Ng
Feb 20, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·C R HamannJ P Thyssen
Apr 16, 2019·The American Journal of Clinical Nutrition·Darcy GüngörJoanne M Spahn
Sep 5, 2020·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·Yu-Hsuan LinChia-Hung Kao
Sep 28, 2018·The Medical Journal of Australia·Lauren S WhiteMichael Kamm
Feb 3, 2020·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ashwin N AnanthakrishnanSiew C Ng
May 29, 2021·Therapeutic Advances in Gastroenterology·Robyn LaubeRupert W Leong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.